Sohini Das &Amp;Amp; Samreen Ahmad

Stories by Sohini Das &Amp;Amp; Samreen Ahmad

Tiger Global back on the prowl in Indian start-up arena

Tiger Global back on the prowl in Indian start-up arena

Rediff.com   6 Dec 2018

The investor has now put together a fund of $3.75 billion to back private companies.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Yulu bikes: Pedal your way to beat the traffic

Yulu bikes: Pedal your way to beat the traffic

Rediff.com   5 Dec 2018

Yulu founder Amit Gupta believes bicycle sharing is the next big thing.

The Complete Man shuns online, sticks to physical stores

The Complete Man shuns online, sticks to physical stores

Rediff.com   17 Nov 2018

In this era of online commerce and virtual shopping, Raymond Ltd, one of India's oldest textile manufacturers and retailers, has tailor-made an offline strategy to maintain a strong foothold in the tier III and IV towns. Samreen Ahmad reports.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Swiggy's losses double, but revenue jumps 4-fold

Swiggy's losses double, but revenue jumps 4-fold

Rediff.com   29 Oct 2018

Swiggy had in June entered the elite Unicorn club after raising $210 million from a group of investors

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Akshaya Patra takes tech help to better feed 1,761,734 children a day

Akshaya Patra takes tech help to better feed 1,761,734 children a day

Rediff.com   11 Oct 2018

Its newly-built Jigani kitchen in Bengaluru is piloting the use of technologies such as data analytics, blockchain and Internet of Things to speed up the huge volume of its operations while ensuring strict quality control, reports Samreen Ahmad.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com   10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Britannia wants to makes 100th year memorable

Britannia wants to makes 100th year memorable

Rediff.com   7 Oct 2018

Britannia, which is celebrating its centenary year in 2018, will first look at expanding its dairy and bakery businesses, before turning its attention towards new food categories. The attempt is to become a total foods company, as it eyes a well-rounded presence in the market.

Homes get smarter, are you ready?

Homes get smarter, are you ready?

Rediff.com   29 Sep 2018

Smart homes that do your everyday tasks are now coming on the Indian market. Several real estate firms are making this reality as they venture into constructing automated homes.

Why draft pharma policy may take time to see light of day

Why draft pharma policy may take time to see light of day

Rediff.com   25 Sep 2018

Some of the proposals (for example trade margin calculation for imported medical devices) were not approved by the PMO and were sent back for revisions.

How Amul is quelling the 'non-veg' rumours

How Amul is quelling the 'non-veg' rumours

Rediff.com   21 Sep 2018

This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.

For Singh brothers, truce is temporary, split only way out

For Singh brothers, truce is temporary, split only way out

Rediff.com   15 Sep 2018

NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.

Shivinder vs Malvinder: Mother helps avoid legal battle for now

Shivinder vs Malvinder: Mother helps avoid legal battle for now

Rediff.com   14 Sep 2018

Sources said she had stopped eating for the past few days and had constantly been making calls and sending emails to the two brothers.

Faulty hip implants: Centre to ask J&J to compensate victims

Faulty hip implants: Centre to ask J&J to compensate victims

Rediff.com   30 Aug 2018

Once the patients are identified, the government will decide on the quantum of compensation in each case and then approach J&J for claim settlement.

Soon, you will be able to be 'Vokal' in 6 regional languages

Soon, you will be able to be 'Vokal' in 6 regional languages

Rediff.com   20 Aug 2018

TaxiForSure's Aprameya Radhakrishna's new venture, Vokal, is a peer-to-peer content generation platform that is a cross between Reddit and Quora.

How Manipal plans to spread its wings in India

How Manipal plans to spread its wings in India

Rediff.com   16 Aug 2018

Rough estimates show that at a rate of Rs 1 crore per hospital bed, the investment in India alone would be around Rs 2,000 crore

How Allergan plans to boost Botox sales in Indian market

How Allergan plans to boost Botox sales in Indian market

Rediff.com   15 Aug 2018

While the Botox segment is growing annually at around 20-25% in the country, Allergan India's aesthetics business is growing at 60%